ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Digital Immunoassay PSA Test May Predict Cancer Recurrence

October 28, 2011

In Brief: Community ASSN. Developing Clinical Standards Catalogue; Perry Leaves NCI For NIH Position

November 15, 1974

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979

ACS To Continue Supporting Both Treatment, Prevention Research, Leaders Say

May 1, 1987

Ethics Commission Say HHS Should Test Injury Compensation

June 18, 1982